- Home
- ADMA vs GENI Comparison
ADMA vs GENI Comparison
Compare ADMA & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- GENI
- Stock Information
- Founded
- ADMA 2004
- GENI 2016
- Country
- ADMA United States
- GENI United Kingdom
- Employees
- ADMA N/A
- GENI N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- GENI Services-Misc. Amusement & Recreation
- Sector
- ADMA Health Care
- GENI Consumer Discretionary
- Exchange
- ADMA Nasdaq
- GENI Nasdaq
- Market Cap
- ADMA 3.5B
- GENI 3.0B
- IPO Year
- ADMA N/A
- GENI N/A
- Fundamental
- Price
- ADMA $16.18
- GENI $10.48
- Analyst Decision
- ADMA Strong Buy
- GENI Strong Buy
- Analyst Count
- ADMA 3
- GENI 17
- Target Price
- ADMA $27.67
- GENI $13.88
- AVG Volume (30 Days)
- ADMA 3.7M
- GENI 5.4M
- Earning Date
- ADMA 11-05-2025
- GENI 11-04-2025
- Dividend Yield
- ADMA N/A
- GENI N/A
- EPS Growth
- ADMA 205.35
- GENI N/A
- EPS
- ADMA 0.86
- GENI N/A
- Revenue
- ADMA $488,559,000.00
- GENI $604,524,000.00
- Revenue This Year
- ADMA $21.08
- GENI $28.54
- Revenue Next Year
- ADMA $25.98
- GENI $17.14
- P/E Ratio
- ADMA $18.73
- GENI N/A
- Revenue Growth
- ADMA 27.63
- GENI 30.70
- 52 Week Low
- ADMA $13.50
- GENI $7.76
- 52 Week High
- ADMA $25.67
- GENI $13.73
- Technical
- Relative Strength Index (RSI)
- ADMA 58.69
- GENI 32.83
- Support Level
- ADMA $13.76
- GENI $10.26
- Resistance Level
- ADMA $15.65
- GENI $10.48
- Average True Range (ATR)
- ADMA 0.78
- GENI 0.42
- MACD
- ADMA 0.12
- GENI -0.11
- Stochastic Oscillator
- ADMA 93.92
- GENI 22.84
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.